| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2026 | Modicus Prime: $8 Million Raised To Expand AI Compliance Infrastructure For Pharma | Modicus Prime announced it raised a total of $8 million in funding following an additional $4.5 million investment led by Frist Cressey Ventures, with participation from Silverton Partners and Oncology Ventures.
The company said the financi... |
| Aug 1, 2025 | Houston's 13 best midsize companies and more innovation news to know | Editor's note: The top innovation news from the second half of the month includes new leaders at innovative Houston organizations and a ranking of the best midsize businesses from Time. Here are the five most-read InnovationMap stories from... |
| Jul 31, 2025 | Houston tech jobs to grow in 2025 as Texas leads U.S. in new tech employment | Tech employment in the Houston metro area is expected to climb by more than two percent this year, according to a new projection.
CompTIA’s State of the Tech Workforce 2025 report forecasts the Houston area will employ 158,176 tech professi... |
| Jun 14, 2024 | Singapore Science Park: An industry campus evolves into a hotspot for work, play and living | Listen to this article
Singapore Science Park: An industry campus evolves into a hotspot for work, play and living
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
How does your workday typically begin?
Imag... |
| Jun 16, 2022 | BIO: 'Diversity candidates' and knowledge 'shortfalls': Women in biotech say 'I'm here to do my job' despite toxic tropes | The script at BIO this year could not have been more clear: Progress on diversity is being made, but more work needs to be done. Yet still, an undercurrent of biotech’s all-boys brand-of-old tugged at the heels of efforts to bolster those l... |
| May 12, 2022 | ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray | ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk populations and pandemic preparedness, has been selected... |
| May 11, 2022 | ENA Respiratory Selected for BLUE KNIGHT™ to Accelerate Development of Pan-Antiviral Nasal Spray | SYDNEY, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pan-antiviral prophylaxis in at-risk popu... |
| Feb 23, 2022 | BIORCHESTRA Announces 45 Million USD Series C Fundraising | SEOUL, South Korea, Feb. 23, 2022 /PRNewswire/ -- BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using its proprietary RNA-based drug and drug delivery platforms. Today, BIORCHESTRA... |
| Oct 5, 2021 | Акселераторы, о которых должны знать MedTech-стартапы | Акселераторы, о которых должны знать MedTech-стартапы |
| Oct 5, 2021 | Must-know accelerators for MedTech-startups | Must-know accelerators for MedTech-startups |
| Sep 23, 2021 | BIORCHESTRA appoints pharma veteran and Moderna and Akcea (Ionis) CMO "Dr. Louis St. L. O'Dea" as CMO of BIORCHESTRA | BOSTON, Sept. 23, 2021 /PRNewswire/ -- BIORCHESTRA is a bio-tech company focused on the identification of novel targets in neurodegenerative diseases using RNA-based therapeutics. To access these novel targets, BIORCHESTRA has also develope... |
| Aug 16, 2021 | 60 полезных сайтов для поиска инвестиций в стартап | 60 полезных сайтов для поиска инвестиций в стартап |
| Feb 1, 2021 | Johnson & Johnson : Named a 2021 Fortune World's Most Admired Company | Innovation. Equity. Sustainability. Responsibility. Caring.
These values underscore everything that Johnson & Johnson does, from innovating new medicines to accelerating work to promote health equity and ensuring its products meet the h... |
| Jan 27, 2021 | A New Perspective On How To Fix Pharma’s Broken Business Model | Biopharma has brought miracle cures. With leadership, the industry could do so much more. getty |
| Nov 20, 2020 | High Drug Prices, Low Productivity, Resistance To Change: Pharma’s Dysfunctional Business Model | US President Donald Trump and Vice President Mike Pence, along with members of the coronavirus task ... [+] force meet with pharmaceutical executives in the Cabinet Room of the White House (Photo by MANDEL NGAN/AFP via Getty Images)AFP via ... |
| Nov 2, 2020 | The precision medicine conference you don’t want to miss | Some of the topics that will be discussed at the conference include:
Reimbursement models for cell and gene therapies
Interoperability progress report
What does the diagnostics landscape look like?
Investment trends in precision medicine
St... |
| Oct 8, 2020 | Why I’m optimistic about Philly tech, and why you should be, too: Notes from a former investor | It’s really freakin’ hard to build a company. In fact, there’s no rational reason to do so.
According to private equity research company CB Insights, 42% of the time your startup will fail due to lack of a market need for the product, about... |
| Aug 9, 2020 | VenoStent has a new technology to improve outcomes for dialysis patients | Timothy Boire and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
Failed dialysi... |
| Feb 20, 2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| Dec 16, 2019 | New drug development: ‘It’s the ecosystem, stupid’ | A trio of biopharma observers recently published in STAT an analysis relevant to the ongoing drug pricing debate in Washington. The response has not been pretty. In short, the authors suggest that since two reviewed pharmaceutical companies... |
| Nov 21, 2019 | Virginia Tech is partnering with Children’s National Hospital on a biomedical research facility | Virginia Tech is partnering with Children’s National Hospital to bring a biomedical research facility to the hospital’s new Children’s National Research & Innovation Campus in the District.
Children’s National takes up a 12-acre portion... |
| Oct 8, 2019 | DC: Here are your nominees for the 2019 Technical.ly Awards | Every day, we at Technical.ly talk to technologists, entrepreneurs and leaders building in D.C. They span different categories of company and job title, and have different paths and plans for getting to the ultimate destination.
Through the... |
| Jul 1, 2019 | Women Who Tech Launches HealthTech Innovation Program, Calls For Europe Startup Challenge Applications | Women Who Tech, a nonprofit organization that funds and showcases women-led ventures, announced it is calling for applications for the European leg of its flagship Startup Challenge program focused on healthtech
Women Who Tech, a nonprofit ... |
| May 28, 2019 | Beyond Coworking: Homegrown Innovation Spaces Are Transforming Second Cities | Opening summer 2019, The Cannon in Houston, TX will be a 120,000 square foot startup community. The Cannon Houston |
| Dec 14, 2018 | Startup Spotlight: PanTher’s drug-delivery patch aims to knock down the ‘wall’ of pancreatic cancer | Wherever there has been a stage for biotech entrepreneurs this fall, Laura Indolfi has appeared. And wherever she is, major pharmaceutical companies have been, too.
Indolfi’s company, Cambridge, Mass.-based PanTher Therapeutics, has already... |
| Sep 4, 2018 | What incubators and tech ecosystems can offer health startups | Kate Merton Contributor
Kate Merton, PhD, is the head of NYC + Boston @JLABS, a global life sciences and health innovation hub.
Access to connections with industry and market know-how is critical for ventures looking to scale beyond a Serie... |
| Jul 18, 2018 | Johnson & Johnson to open its first US ‘networking hub’ at Pennovation | Johnson & Johnson announced Wednesday it has picked the University of Pennsylvania’s Pennovation Center to house its first U.S.-based JPOD, a networking hub that looks to create a bridge between J&J researchers and the local life sc... |
| May 3, 2018 | Inside New York City's struggle to become a biotech hub | Hollis Johnson
Advertisement
Biotech companies of all shapes and sizes have started to make New York - a city known more for banks than biotech - their home.
But while the city is home to major pharmaceutical company headquarters and academ... |
| Feb 27, 2018 | Boost Biomes Launches Microbe Discovery Platform with $2m Seed Round | San Francisco-based Boost Biomes has raised a $2.05 million seed round to continue to develop its DNA-sequencing- based microorganism discovery platform, led by Nimble Ventures and hedge fund Viking Global Investors. Chinese internet, mobil... |
| Dec 22, 2017 | Toronto’s thriving AI ecosystem serves as a model for the world | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
While you were looking the other way, Toronto hum... |
| Nov 20, 2017 | Texas Medical Center joins a growing list of health systems with venture funds | An investment committee for the fund includes representatives from TMC, MD Anderson Cancer Center, Baylor College of Medicine, Texas Children’s Hospital, JLABS @ TMC, Versalius Ventures and Houston Angel Network.
“The venture capital fund h... |
| Sep 21, 2017 | 20 Startup Accelerators Impacting the Healthcare Industry | Startup accelerators are all about support. They gives budding companies a chance to succeed thanks to mentorship, networking opportunities, and plenty of capital. In the healthcare industry, those kinds of resources aren't found easily, pa... |
| May 29, 2017 | 5 medtech companies to watch at JLABS @ Toronto | Like a blood test looking for biological markers, WinterLight’s technology seeks to isolate cadence, word choice and other voice markers that might indicate a neurological issue.
“Different disorders have different clusters of variables ass... |
| Mar 23, 2017 | Johnson & Johnson Innovation Launches Singapore QuickFire Challenge Competition in Collaboration with ETPL and SMART to Accelerate Solutions for Diabetes and Other Metabolic Diseases | SINGAPORE, March 23, 2017 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., announced today a collaboration with A*STAR's ETPL, through its Diagnostics Development Hub, and Singapor... |
| Dec 14, 2016 | J&J incubator alumnus Ab Initio inks GPCR antibody deal with Pfizer | South San Francisco’s I/O biotech Ab Initio has penned a deal with Big Pharma Pfizer that will help fund the fledging company’s platform expansion.
Ab Initio, which came out of Johnson & Johnson’s Bay Area biotech incubator program just... |
| Aug 24, 2016 | Chinese-backed developer gets OK for $1B biotech campus on SF Bay | Greenland USA said it’s too soon after the deal, announced on Aug. 18, to say just which anchor tenants they’ll court for this new complex. But the biotech direction makes sense given the industry’s growth and the city of South San Francisc... |
| Texas Medical Center joins a growing list of health systems with venture funds | Texas Medical Center’s launch of the $25 million TMC Venture Fund adds the organization to a growing list of institutions that have made investing in early stage healthcare startups part of their strategy for cultivating innovation across t... |
| The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| 5 medtech companies to watch at JLABS @ Toronto | With more than 40 companies on its roster, Johnson & Johnson Innovation’s life sciences incubator JLABS @ Toronto is celebrating a successful first year. One of eight such facilities around North America, JLABS provides early stage star... |
| Chinese-backed developer gets OK for $1B biotech campus on SF Bay | Rendering of the planned Landing at Oyster Point development in South San Francisco, California.
It took eight years, a team of developers, marketers, city officials and one of China’s biggest state-backed developers. But with the infusion ... |
| The precision medicine conference you don’t want to miss | Mark your calendars. MedCity’s INVEST Precision Medicine virtual conference is coming up December 9-11. The summit gathers directors through the C-suite from across healthcare sectors to discuss new developments in precision medicine, inves... |